These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29309927)

  • 1. Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer.
    Nagini S; Sophia J; Mishra R
    Semin Cancer Biol; 2019 Jun; 56():25-36. PubMed ID: 29309927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
    McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
    Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers.
    Bertrand FE
    Biochim Biophys Acta Mol Cell Res; 2020 Sep; 1867(9):118738. PubMed ID: 32389646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.
    McCubrey JA; Fitzgerald TL; Yang LV; Lertpiriyapong K; Steelman LS; Abrams SL; Montalto G; Cervello M; Neri LM; Cocco L; Martelli AM; Laidler P; Dulińska-Litewka J; Rakus D; Gizak A; Nicoletti F; Falzone L; Candido S; Libra M
    Oncotarget; 2017 Feb; 8(8):14221-14250. PubMed ID: 27999207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer.
    Tejeda-Muñoz N; Robles-Flores M
    IUBMB Life; 2015 Dec; 67(12):914-22. PubMed ID: 26600003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
    Wang Q; Zhou Y; Wang X; Evers BM
    Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.
    Sahin I; Eturi A; De Souza A; Pamarthy S; Tavora F; Giles FJ; Carneiro BA
    Cancer Biol Ther; 2019; 20(8):1047-1056. PubMed ID: 30975030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
    Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
    Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3--an overview of an over-achieving protein kinase.
    Kockeritz L; Doble B; Patel S; Woodgett JR
    Curr Drug Targets; 2006 Nov; 7(11):1377-88. PubMed ID: 17100578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer.
    Evangelisti C; Chiarini F; Paganelli F; Marmiroli S; Martelli AM
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118635. PubMed ID: 31884070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
    Khan I; Tantray MA; Alam MS; Hamid H
    Eur J Med Chem; 2017 Jan; 125():464-477. PubMed ID: 27689729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
    Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
    Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.
    Piazza F; Manni S; Tubi LQ; Montini B; Pavan L; Colpo A; Gnoato M; Cabrelle A; Adami F; Zambello R; Trentin L; Gurrieri C; Semenzato G
    BMC Cancer; 2010 Oct; 10():526. PubMed ID: 20920357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
    Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC
    Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting GSK3 and Associated Signaling Pathways Involved in Cancer.
    Duda P; Akula SM; Abrams SL; Steelman LS; Martelli AM; Cocco L; Ratti S; Candido S; Libra M; Montalto G; Cervello M; Gizak A; Rakus D; McCubrey JA
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of glycogen synthase kinase 3 in human neutrophils.
    Giambelluca MS; Cloutier N; Rollet-Labelle E; Boilard E; Pouliot M
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2660-5. PubMed ID: 24035907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
    Zhang K; Song H; Yang P; Dai X; Li Y; Wang L; Du J; Pan K; Zhang T
    Cell Prolif; 2015 Apr; 48(2):249-58. PubMed ID: 25643607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
    Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.
    Saraswati AP; Ali Hussaini SM; Krishna NH; Babu BN; Kamal A
    Eur J Med Chem; 2018 Jan; 144():843-858. PubMed ID: 29306837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.